Greenflex MP 35 EVA Copolymer Resin,High Elasticity Injection Molding Grade

Grade characterization establishes the processing envelope before downstream specification work begins. Greenflex MP 35 is an ethylene-vinyl acetate copolymer containing 35 wt% vinyl acetate comonomer, classified as a high-elasticity injection molding grade in which the amorphous character of the vinyl acetate fraction suppresses polyethylene crystallinity. Published data for this specific lot configuration indicates Shore A hardness within 75–85 (ISO 868), tensile elongation at break exceeding 700% under ISO 527-2 protocols, and a melt flow rate of 5–15 g/10 min at 190 °C/2.16 kg per ISO 1133-1:2022. The Vicat softening temperature remains below 60 °C (ISO 306, Method A50), which constrains all post-molding thermal exposure. Melt temperature must not exceed 185 °C; sustained operation above that threshold initiates deacetylation of the vinyl acetate ester group, releasing acetic acid and producing visible yellowing, embrittlement, and lot-to-lot viscosity drift. The grade contains no plasticizer and no heavy-metal stabilizer, a formulation constraint that materially affects migration behavior in regulated end uses. All downstream application scenarios below assume the compound has been stored in sealed packaging below 60% RH; moisture content above 0.05 wt% requires forced-air drying at 50–55 °C for 2–4 hours prior to injection.

Within rotary injection molding cells dedicated to athletic footwear midsole production, the crosslinked EVA foam process imposes the narrowest processing window of any downstream application for this grade. The constraint originates from the thermal decomposition kinetics of the blowing agent and the half-life profile of the peroxide crosslinker. Azodicarbonamide, dosed at 2.0–4.0 phr, exhibits a nominal decomposition onset near 195–215 °C when characterized by differential scanning calorimetry in isolation; however, the presence of zinc oxide (1.0–2.5 phr) and stearic acid (0.5–1.0 phr) as activators shifts the effective decomposition onset downward to approximately 155–165 °C. Dicumyl peroxide, charged at 0.4–0.8 phr, delivers a half-life of roughly 5–8 minutes at 155 °C and 1–2 minutes at 170 °C, meaning the mold must be maintained at 155–170 °C to trigger simultaneous crosslinking and blowing while the barrel must remain below 115 °C to prevent premature gas evolution and scorch-induced non-return valve seizure. Rotary injection molding machines configured with 8–24 stations and per-station clamp force between 100–500 tonnes are the standard production equipment; cycle times range from 300–720 seconds depending on midsole thickness and target foam density. Barrel zone temperatures are maintained at 85–110 °C, screw back pressure is kept below 20 bar, and shot volume is calibrated to 60–80% of cavity volume to accommodate foam expansion. Batch-to-batch variation in azodicarbonamide particle size distribution has been observed on actual production lines to alter nucleation density and produce midsole density deviations up to ±0.03 g/cm³ within a single shift if the blowing agent is not pre-screened to a D50 below 10 µm. Post-demold shrinkage of 1.8–2.6% stabilizes over 24–48 hours; premature dimensional inspection before this aging period yields false rejection rates exceeding 8% in high-volume footwear manufacturing. End product density ranges from 0.12–0.35 g/cm³, with Shore C hardness of 30–55 and compression set below 20% per ASTM D395 Method B at 50 °C/22 h. Finished midsoles manufactured under this regimen enter athletic footwear, casual dock shoes, and footbed cushioning systems.

What Limits Sterilization Regimen Selection for EVA Medical Components?

The selection of sterilization modality for injection-molded EVA medical device components manufactured from this grade is constrained by the Vicat softening temperature of 40–60 °C relative to the 121 °C/15-minute minimum exposure specified for steam autoclave cycles under ISO 17665-1:2006. Unrestrained parts subjected to steam sterilization exhibit dimensional distortion exceeding 3% in wall sections thinner than 2 mm, and the high amorphous content of the 35 wt% vinyl acetate fraction accelerates water vapor absorption, producing surface blistering when the part returns to ambient temperature. Ethylene oxide sterilization conducted at 55 °C and 30–60% RH is operationally compatible with the material but requires extended post-cycle aeration: residual EtO desorption rates for high-VA EVA copolymers have been documented to require 24–48 hours under forced ventilation at 45–50 °C before residual gas concentration falls below the 4 mg/device limit referenced in ISO 10993-7. Gamma irradiation at 25 kGy, the conventional single-dose validation range for single-use devices, produces measurable chain scission in the vinyl acetate side groups; published data for this specific configuration is limited, and each lot must be verified for post-irradiation tensile retention. Biocompatibility documentation under ISO 10993-1 requires cytotoxicity testing per ISO 10993-5 using MEM elution extracts prepared according to ISO 10993-12 (37 °C/24 h extraction), sensitization testing per ISO 10993-10, and USP <88> Class VI systemic toxicity, intracutaneous reactivity, and implantation evaluation for devices contacting tissue. FDA 21 CFR 177.1350 establishes that EVA copolymers containing up to 50 wt% vinyl acetate are permissible for food-contact articles, with the extractable fraction in n-hexane at reflux temperature not exceeding 5.5 wt%. Cleanroom injection molding for direct patient contact devices typically operates at ISO 13485 quality system conditions within an ISO 7 classified environment, using barrel temperatures of 130–155 °C and mold temperatures of 15–25 °C to minimize volatile organic condensation on cavity surfaces. Formulations for medical applications are typically additive-restricted: antioxidant loading at 0.05–0.15 phr with no slip agent, no mold release carryover exceeding 0.01 wt%, and no peroxide residuals. End product categories include respiratory mask cushions, CPAP interface components, urine collection bag connectors, syringe plunger tips, and infant care device gaskets.

Soft-Touch Overmolding onto Polar Thermoplastic Substrates

Two-shot injection molding and insert molding represent the primary process routes by which this high-elasticity EVA grade is overmolded onto polypropylene, polyamide 6, and polycarbonate substrates in hand tool and consumer electronics manufacturing. The bond mechanism between the EVA second shot and the substrate first shot is predominantly mechanical interlocking at the interface; no covalent bond forms between EVA and non-polar polypropylene without an intervening compatibilizer or primer. On two-shot machines with a rotary platen, the substrate is partially cooled to 60–80 °C before the second barrel discharges at 160–175 °C melt temperature, delivering peel strength values between 2–5 N/mm when tested per ASTM D903 at 90° peel angle and 50 mm/min crosshead speed. Incorporation of a maleic anhydride-grafted compatibilizer at 2–5 wt% into the EVA second-shot compound increases peel strength to 5–10 N/mm by promoting interfacial polar interaction with hydroxyl and amine surface groups on the substrate. Insert molding of pre-molded glass-fiber-reinforced nylon handles is executed with the substrate preheated to 80–120 °C to prevent differential shrinkage from shearing the mechanical interlock during cooling; mold temperatures for the EVA overmold are maintained at 20–40 °C, injection pressure held at 600–1000 bar, and hold pressure at 300–500 bar for 2–4 seconds before cooling. A documented operational failure mode on production lines involves mold release agent carryover exceeding 0.05 wt% on the substrate surface, which produces localized peel strength collapse below 1 N/mm and visual delamination within 500 hand flex cycles. The compound is modified with 0.05–0.2 phr erucamide slip agent and 0.05–0.2 phr hindered phenolic antioxidant for demolding and thermal stabilization during melt residence times up to 6 minutes. End product assemblies include power tool soft grips, kitchen utensil handles, razor handle overmolds, and overmolded mouse side grips for office peripherals.

Because the flexural modulus of this 35 wt% vinyl acetate copolymer remains below 25 MPa even at 0 °C, the material fulfills the cold-flex requirement specified in IEC 60601-1 clause 8.10.3 for medical electrical equipment cable anchorage without the brittleness failures observed in rigid PVC strain reliefs. Cable strain relief and grommet production is typically executed on vertical injection molding machines with shot weights between 0.5–8.0 g; barrel temperature is maintained at 140–160 °C, mold temperature at 15–25 °C, and cycle time from 12–25 seconds. The compound for electrical applications is modified with aluminum trihydroxide at 10–25 wt% to achieve UL 94 HB classification at 1.5 mm thickness; antimony trioxide is avoided because it creates opacity, increases viscosity, and introduces heavy-metal compliance risk under RoHS 2011/65/EU. The non-return valve in the reciprocating screw is a documented wear point when processing filled EVA compounds: the abrasive character of aluminum trihydroxide accelerates valve clearance growth beyond 0.15 mm within 8,000–12,000 shot cycles, producing shot-to-shot viscosity deviation that manifests as incomplete cavity fill on grommets with wall sections below 1 mm. Antioxidant loading at 0.1–0.3 phr is required to prevent surface oxidation during sustained residence times; hot runner tips must be maintained below 170 °C to avoid acetic acid evolution that corrodes polished tool steel. Compliance documentation for this segment requires RoHS substance testing per IEC 62321 series; dielectric strength tested per ASTM D149 at 2 mm thickness typically falls in the range of 30–40 kV/mm, and volume resistivity per ASTM D257 exceeds 10¹⁴ Ω·cm. End product categories include power cord strain relief boots, automotive bulkhead grommets, USB cable terminations, and internal wire routing bushings for appliance harnesses.

When DCP Crosslinking Alters the Foam Density–Compression Set Tradeoff in Impact Protective Padding

Injection-molded impact protective padding manufactured from crosslinked EVA foam represents a distinct formulation space from athletic footwear, despite sharing the blowing agent and peroxide chemistry framework. The performance target in this application is energy absorption rather than cushioning resilience, which translates into a higher crosslink density and a moderate foam density range of 0.15–0.25 g/cm³. Dicumyl peroxide loading is increased to 0.5–1.0 phr to elevate gel content and reduce compression set; the resulting gel fraction, measurable by solvent extraction in boiling xylene for 24 hours, typically falls between 65–85 wt%. Azodicarbonamide is charged at 1.5–3.0 phr with zinc oxide activator at 1.0–2.0 phr; calcium carbonate filler at 5–10 phr is added to increase plateau stress during impact compression. The injection molding process mirrors the footwear midsole regimen: rotary equipment with mold temperature held at 155–170 °C, barrel below 115 °C, and total cycle time from 240–480 seconds for thinner padding profiles. Force transmission through the molded pad must not exceed 35 kN under EN 1621-1:2012 impact protocols for limb joint protectors; ASTM F1292-18 governs playground surfacing impact attenuation where head injury criterion values must remain below 1000 at a drop height of 1.8 meters. Rebound resilience measured per ISO 8307 typically falls between 35–45% for this formulation class, deliberately lower than the 50–60% achieved in footwear midsoles to prevent secondary rebound injuries in motorcycling and contact sports applications. Compression set per ASTM D395 Method B at 50 °C/22 h is specified below 15% to maintain dimensional stability through repeated impact cycles. Temperature sensitivity in service is a boundary condition: continuous exposure above 70 °C accelerates creep in the foam structure, making the material unsuitable for helmet outer shells and other components bearing sustained mechanical load at elevated temperatures. End product applications include ice hockey shoulder pad liners, motorcycle body armor inserts, knee and elbow protectors for cycling, and play surface underlay tiles.

Sealing Element Migration Kinetics Under EU 10/2011 Simulant D

Closure liners and sealing elements injection-molded from this grade fall under direct food-contact regulatory jurisdiction when the finished article contacts packaged food or beverage. EU Regulation 10/2011 mandates overall migration testing under standardized conditions; for closures intended for fatty foods, Simulant D1 (50% ethanol) at 40 °C for 10 days or Simulant D2 (vegetable oil) at 20 °C for 10 days applies, with the overall migration limit set at 10 mg/dm². Vinyl acetate monomer is assigned a specific migration limit of 12 mg/kg under Annex I of the regulation; analytical determination is performed by headspace gas chromatography after extraction per EN 13130-6. Under FDA 21 CFR 177.1350, EVA copolymers for food contact are subject to extractable fraction analysis in n-hexane, with the limit set at 5.5 wt% for articles intended for repeat-use contact. The absence of plasticizer in this grade simplifies migration documentation, because no phthalate or adipate leachables require disclosure under EU 10/2011 Annex II. Formulation for closure liner applications uses 0.5–1.5 phr azodicarbonamide where a foamed liner is specified at density 0.35–0.50 g/cm³, or no blowing agent where a solid liner is specified at density 0.94–0.97 g/cm³; nucleating agent at 0.5–2.0 phr is included in foamed liners to achieve cell size uniformity below 100 µm. Injection-compression molding is the preferred process route over conventional injection molding because it generates lower residual stress that would otherwise produce seal face curl after demolding; the process operates at melt temperature 150–165 °C, mold temperature 15–25 °C, and compression stroke timing that initiates closure when the melt has filled 70–80% of the cavity volume. Compression set per ASTM D395 Method B at 23 °C/22 h is controlled below 25% to maintain sealing force over package shelf life; elevated-temperature compression set at 70 °C/22 h is specified below 45%. Sealing force measurement per ASTM F36 (Procedure A) requires compressive load retention of at least 60% after 72 hours at 23 °C for tamper-evident cap liner applications. End product categories include jam jar gaskets, beverage closure liners, tamper-evident induction seal backing pads, and cosmetic jar dispensing orifice seals.

Orthotic and podiatric device manufacturing has progressively shifted from compression-molded LDPE and slab-stock EVA sheet to direct injection molding of high-elasticity EVA grades, driven by the requirement for consistent Shore A hardness, minimal void content, and the elimination of secondary die-cutting operations. Functional foot orthoses and accommodative insoles produced from this grade are injection molded into cast aluminum molds at barrel temperatures of 130–155 °C, mold temperatures of 10–20 °C, and wall thicknesses from 3–8 mm; the low melt viscosity at the upper processing range permits flow through long, thin shell geometries without the molded-in stress that produces heel cup cracking under cyclic loading. The compound is modified with 5–15 phr of a low-molecular-weight EVA wax or oxidized polyethylene to improve injection flow without the plasticizer migration that disqualifies the part from prolonged skin-contact use in diabetic footwear applications. ISO 22523:2006 establishes general requirements for external limb prostheses and orthoses; ISO 22675:2016 specifies fatigue testing for prosthetic ankle-foot devices, requiring 2 million loading cycles without crack propagation. Flex fatigue resistance at the Shore A 75–85 hardness window is verified by repeated bending over a 10 mm mandrel for 100,000 cycles without visible surface crack formation, a protocol adapted from SATRA TM163 methodology. The compatibility of this grade with direct insole footbed contouring depends on maintaining dimensional stability after molding: post-molding shrinkage of 1.5–2.0% stabilizes within 24 hours at 23 °C, and premature trimming before this interval produces heel width variation exceeding ±1.5 mm across a production batch. Compression set per ASTM D395 Method B at 23 °C/22 h is specified below 20%, ensuring that the orthotic retains its corrective contour through 12 months of daily ambulatory loading. End product applications include rigid-shell functional orthoses, accommodative diabetic insoles with metatarsal pads, heel cups for plantar fasciitis management, and over-the-counter arch support inserts.